These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33054976)

  • 1. Corrigendum to "ZSCAN16 promotes proliferation, migration and invasion of bladder cancer via regulating NF-kB, AKT, mTOR, P38 and other genes" [Biomed. Pharmacother. 126 (2020) 110066].
    Li X; Shang D; Shen H; Song J; Hao G; Tian Y
    Biomed Pharmacother; 2020 Oct; 130():110858. PubMed ID: 33054976
    [No Abstract]   [Full Text] [Related]  

  • 2. ZSCAN16 promotes proliferation, migration and invasion of bladder cancer via regulating NF-kB, AKT, mTOR, P38 and other genes.
    Li X; Shang D; Shen H; Song J; Hao G; Tian Y
    Biomed Pharmacother; 2020 Jun; 126():110066. PubMed ID: 32172065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Huachansu capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway" [Biomed. Pharmacother. 118 (2019) 109241].
    Ni T; Wang H; Li D; Tao L; Lv M; Jin F; Wang W; Feng J; Qian Y; Sunagawa M; Liu Y
    Biomed Pharmacother; 2020 Mar; 123():109823. PubMed ID: 31959384
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Baohuoside-1 targeting mTOR inducing apoptsis to inhibit hepatocellular carcinoma proliferation, invasion and migration" [Biomed. Pharmacother. 2020 (128) 110366].
    Guo Y; Zhu H; Weng M; Chen B; Wang C; Sun L
    Biomed Pharmacother; 2020 Oct; 130():110631. PubMed ID: 32828598
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Baohuoside-1 targeting mTOR inducing apoptsis to inhibit hepatocellular carcinoma proliferation, invasion and migration" [Biomed. Pharmacother. 128 (2020) 110366].
    Guo Y; Zhu H; Weng M; Chen B; Wang C; Sun L
    Biomed Pharmacother; 2020 Sep; 129():110394. PubMed ID: 32561180
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "IFI16 promotes cervical cancer progression by upregulating PD-L1 in immunomicroenvironment through STING-TBK1-NF-kB pathway" [Biomed. Pharmacother. 123 (2020) 109790].
    Cai H; Yan L; Liu N; Xu M; Cai H
    Biomed Pharmacother; 2020 Jun; 126():110077. PubMed ID: 32173085
    [No Abstract]   [Full Text] [Related]  

  • 7. 'Corrigendum to "Resveratrol inhibits proliferation, migration and invasion via Akt and ERK1/2 signaling pathways in renal carcinoma cells" [Biomed. Pharmacother. 98 (2018) 36-44]'.
    Zhao Y; Tang H; Zeng X; Ye D; Liu J
    Biomed Pharmacother; 2022 Sep; 153():113329. PubMed ID: 35760645
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "Cerebral dopamine neurotrophic factor protects microglia by combining with AKT and by regulating FoxO1/mTOR signaling during neuroinflammation" [Biomed. Pharmacother. 109 (2018) 2278-2284].
    Zhang Y; Xiang Y; Wang X; Zhu L; Li H; Wang S; Pan X; Zhao H
    Biomed Pharmacother; 2019 Apr; 112():108548. PubMed ID: 30773235
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "MiR-337-3p promotes chondrocytes proliferation and inhibits apoptosis by regulating PTEN/AKT axis in osteoarthritis" [Biomed. Pharmacother. 95 (2017) 1194-1200].
    Huang Z; Zhang N; Ma W; Dai X; Liu J
    Biomed Pharmacother; 2022 Sep; 153():113497. PubMed ID: 35948468
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "MiR-25-3p promotes malignant phenotypes of retinoblastoma by regulating PTEN/Akt pathway" [Biomed. Pharmacother. 118 (2019) 109111].
    Wan W; Wan W; Long Y; Li Q; Jin X; Wan G; Zhang F; Lv Y; Zheng G; Li Z; Zhu Y
    Biomed Pharmacother; 2020 Nov; 131():110842. PubMed ID: 33092949
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Forkhead box D1 promotes proliferation and suppresses apoptosis via regulating polo-like kinase 2 in colorectal cancer" [Biomed. Pharmacother. 103 (2018) 1369-1375].
    Han T; Lin J; Wang Y; Fan Q; Sun H; Tao Y; Sun C
    Biomed Pharmacother; 2022 Sep; 153():113318. PubMed ID: 35738965
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Triptolide inhibits the migration and invasion of human prostate cancer cells via Caveolin-1/CD147/MMPs pathway" [Biomed. Pharmacother. 84 (2016) 1776-1782].
    Yuan S; Wang L; Chen X; Fan B; Yuan Q; Zhang H; Yang D; Wang S
    Biomed Pharmacother; 2020 Feb; 122():109782. PubMed ID: 31862132
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "CRKL knockdown promotes in vitro proliferation, migration and invasion, in vivo tumor malignancy and lymph node metastasis of murine hepatocarcinoma Hca-P cells" [Biomed. Pharmacother. 71 (2015) 84-90].
    Shi J; Meng L; Sun MZ; Guo C; Sun X; Lin Q; Liu S
    Biomed Pharmacother; 2023 Dec; 168():115662. PubMed ID: 37858416
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Cryptotanshinone induces melanoma cancer cells apoptosis via ROS-mitochondrial apoptotic pathway and impairs cell migration and invasion" [Biomed. Pharmacother. 82 (2016) 319-326].
    Ye T; Zhu S; Zhu Y; Feng Q; He B; Xiong Y; Zhao L; Zhang Y; Yu L; Yang L
    Biomed Pharmacother; 2019 Dec; 120():109510. PubMed ID: 31635901
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Amiodarone induces cell proliferation and myofibroblast differentiation via ERK1/2 and p38 MAPK signaling in fibroblasts" [Biomed. Pharmacother. 115 (2019) 108889].
    Weng J; Tu M; Wang P; Zhou X; Wang C; Wan X; Zhou Z; Wang L; Zheng X; Li J; Chen C; Wang Z; Wang Z
    Biomed Pharmacother; 2019 Oct; 118():109085. PubMed ID: 31178264
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression of Concern: "MicroRNA-625-3p promotes the proliferation, migration and invasion of thyroid cancer cells by up-regulating astrocyte elevated gene 1" [Biomed. Pharmacother. 102 (2018) 203-211].
    Biomed Pharmacother; 2022 Aug; 152():113044. PubMed ID: 35725095
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo" [Biomed. Pharmacother. 116 (2019) 109032].
    Weng MC; Li MH; Chung JG; Liu YC; Jeng-Yuan W; Hsu FT; Wang HE
    Biomed Pharmacother; 2019 Oct; 118():109209. PubMed ID: 31324388
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Linc00152 promotes tumorigenesis by regulating DNMTs in triple-negative breast cancer" [Biomed Pharmacother. 97 (2018) 1275-1281].
    Wu J; Shuang Z; Zhao J; Tang H; Liu P; Zhang L; Xie X; Xiao X
    Biomed Pharmacother; 2020 Jul; 127():110174. PubMed ID: 32423656
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Tanshinone IIA inhibits cervix carcinoma stem cells migration and invasion via inhibiting YAP transcriptional activity" [Biomed. Pharmacother. 105 (2018) 758-765].
    Qin J; Shi H; Xu Y; Zhao F; Wang Q
    Biomed Pharmacother; 2019 Oct; 118():109107. PubMed ID: 31227337
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "MicroRNA-769-5p contributes to the proliferation, migration and invasion of hepatocellular carcinoma cells by attenuating RYBP" [Biomed. Pharmacother. 118 (2019) 109343].
    Xian Y; Wang L; Yao B; Yang W; Mo H; Zhang L; Tu K
    Biomed Pharmacother; 2022 Sep; 153():113448. PubMed ID: 35868955
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.